VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ICCC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ICCCImmuCell Corporation
$9.91$90M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksICCCQuarterly Financials

ImmuCell Corporation (ICCC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ImmuCell Corporation (ICCC) quarterly income statement — complete revenue, gross profit & net income history

ICCC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue10.36M7.63M5.51M6.44M8.07M7.75M6.01M5.47M7.26M5.1M5.4M3.53M
Revenue Growth %28.39%-1.61%-8.41%17.76%11.16%52.1%11.4%54.92%110.58%30.3%12.52%-8.51%
Cost of Goods Sold5.7M4.72M3.14M3.63M4.71M4.92M4.43M4.24M4.96M3.84M4.13M2.49M
COGS % of Revenue55.03%61.84%57.08%56.28%58.42%63.47%73.66%77.52%68.37%75.31%76.52%70.45%
Gross Profit4.66M2.91M2.36M2.82M3.35M2.83M1.58M1.23M2.3M1.26M1.27M1.04M
Gross Margin %44.97%38.16%42.92%43.72%41.58%36.53%26.34%22.48%31.63%24.69%23.48%29.55%
Gross Profit Growth %38.86%2.77%49.23%129.01%46.12%125.09%25%17.88%663.15%-20.44%-31.37%-38.86%
Operating Expenses2.69M2.97M2.34M2.25M2.24M2.21M2.16M2.62M2.6M2.26M2.45M2.35M
OpEx % of Revenue25.95%38.92%42.55%34.89%27.72%28.52%35.9%47.82%35.76%44.37%45.42%66.48%
Selling, General & Admin1.23M2.21M1.65M1.42M1.48M1.39M1.37M1.59M1.33M1.2M1.33M1.25M
SG&A % of Revenue11.9%28.97%29.94%21.98%18.34%17.94%22.83%28.99%18.37%23.45%24.69%35.35%
Research & Development317.69K758.86K694.31K831.86K756.85K819.39K786.14K1.03M1.26M1.07M1.12M1.1M
R&D % of Revenue3.07%9.95%12.61%12.91%9.38%10.57%13.08%18.83%17.4%20.92%20.73%31.12%
Other Operating Expenses1000K00000000000
Operating Income1.97M-57.96K20.07K569.56K1.12M621.39K-574.89K-1.39M-300.05K-1M-1.18M-1.3M
Operating Margin %19.01%-0.76%0.36%8.84%13.85%8.02%-9.56%-25.34%-4.13%-19.68%-21.94%-36.93%
Operating Income Growth %76.21%-109.33%103.49%141.08%472.48%161.95%51.45%-6.29%86.7%38.61%-91.97%-110.74%
EBITDA2.5M648.36K699.16K1.24M1.79M1.3M100.23K-715.65K367.2K-318K-483.63K-599.39K
EBITDA Margin %24.11%8.5%12.7%19.21%22.23%16.71%1.67%-13.08%5.06%-6.24%-8.96%-16.97%
EBITDA Growth %39.25%-49.94%597.57%272.96%388.45%507.31%120.72%-19.4%123.09%69.11%-3214%-5876.18%
D&A (Non-Cash Add-back)528.29K706.32K679.09K668.23K675.97K673.85K675.12K670.96K667.25K685K700.41K705.1K
EBIT1.97M-2.74M-135.29K628.58K1.57M645.98K-567.01K-1.39M-290.52K-985.58K-795.15K-1.29M
Net Interest Income-55.31K-71.33K-93.05K-76.68K-90.46K-99.97K-125.46K-129.12K-136.48K0-120.92K-73.77K
Interest Income44.37K31.66K41.47K48.11K37.47K25.42K7.88K13.26K9.53K023.7K14.81K
Interest Expense99.67K102.99K134.52K124.8K127.93K125.39K133.34K142.39K146K0144.62K88.58K
Other Income/Expense-15.19K-2.79M-155.37K-65.78K331.26K-100.8K-125.46K-143.68K-136.48K-134.5K244.28K-73.69K
Pretax Income1.95M-2.85M-135.29K503.78K1.45M520.59K-700.35K-1.53M-436.53K-1.14M-939.77K-1.38M
Pretax Margin %18.87%-37.32%-2.46%7.82%17.96%6.72%-11.65%-27.96%-6.01%-22.33%-17.41%-39.01%
Income Tax12.52K3.31K4.46K1.9K1.9K6.04K1.34K1.34K1.34K2K2291.52K
Effective Tax Rate %0.64%-0.12%-3.29%0.38%0.13%1.16%-0.19%-0.09%-0.31%-0.18%-0.02%-0.11%
Net Income1.94M-2.85M-139.75K501.88K1.45M514.55K-701.69K-1.53M-437.87K-1.14M-940K-1.38M
Net Margin %18.75%-37.36%-2.54%7.79%17.94%6.64%-11.67%-27.99%-6.03%-22.37%-17.42%-39.06%
Net Income Growth %34.18%-653.71%80.08%132.77%430.46%145.14%25.35%-11.01%81.09%31.65%-43.49%-101.67%
Net Income (Continuing)1.94M-2.85M-139.75K501.88K1.45M514.55K-701.69K-1.53M-437.87K-1.14M-940K-1.38M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)0.21-0.31-0.020.060.160.06-0.09-0.20-0.06-0.15-0.12-0.18
EPS Growth %31.25%-638.19%82.07%127.8%383.19%138.4%28.42%-11.11%81.17%31.82%-42.01%-103.85%
EPS (Basic)0.21-0.31-0.020.060.160.06-0.09-0.20-0.06-0.15-0.12-0.18
Diluted Shares Outstanding9.05M9.05M9.05M9.03M8.98M8.94M8.16M7.81M7.75M7.75M7.75M7.75M
Basic Shares Outstanding9.05M9.05M9.05M9.03M8.98M8.94M8.16M7.81M7.75M7.75M7.75M7.67M
Dividend Payout Ratio------------